Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Depreciation & Amortization (CF) (2018 - 2025)

Historic Depreciation & Amortization (CF) for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $7.5 million.

  • Viemed Healthcare's Depreciation & Amortization (CF) rose 1764.98% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $27.4 million, marking a year-over-year increase of 998.35%. This contributed to the annual value of $25.4 million for FY2024, which is 1603.7% up from last year.
  • Per Viemed Healthcare's latest filing, its Depreciation & Amortization (CF) stood at $7.5 million for Q3 2025, which was up 1764.98% from $6.9 million recorded in Q2 2025.
  • Viemed Healthcare's Depreciation & Amortization (CF)'s 5-year high stood at $7.5 million during Q3 2025, with a 5-year trough of $2.6 million in Q1 2021.
  • Its 5-year average for Depreciation & Amortization (CF) is $5.0 million, with a median of $5.2 million in 2023.
  • Per our database at Business Quant, Viemed Healthcare's Depreciation & Amortization (CF) soared by 4498.91% in 2023 and then skyrocketed by 521.88% in 2025.
  • Over the past 5 years, Viemed Healthcare's Depreciation & Amortization (CF) (Quarter) stood at $3.1 million in 2021, then skyrocketed by 40.16% to $4.4 million in 2022, then soared by 35.35% to $5.9 million in 2023, then increased by 7.55% to $6.4 million in 2024, then rose by 18.43% to $7.5 million in 2025.
  • Its Depreciation & Amortization (CF) stands at $7.5 million for Q3 2025, versus $6.9 million for Q2 2025 and $6.6 million for Q1 2025.